What is Brief History of FIGS Company?

FIGS Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

How Did FIGS Revolutionize the Healthcare Apparel Industry?

Imagine a world where healthcare professionals are not only equipped with the best tools but also feel confident and comfortable in their uniforms. FIGS, a company that started with a simple observation, has fundamentally changed the landscape of medical apparel. This FIGS SWOT Analysis reveals how this scrub brand transformed a stagnant industry into a dynamic, lifestyle-focused market.

What is Brief History of FIGS Company?

The FIGS company story is one of innovation and disruption, born from a clear understanding of the needs of healthcare workers. From its founding in 2013, FIGS history is marked by a commitment to quality, design, and community building. The company's success in the medical apparel sector highlights its effective marketing strategy and its ability to resonate with its target audience, setting it apart from competitors. Understanding the brief history of FIGS provides crucial insights into its current market position and future potential.

What is the FIGS Founding Story?

The story of the FIGS company began in 2013, driven by a clear vision to revolutionize the medical apparel industry. Founders Heather Hasson and Trina Spear identified a significant gap in the market, aiming to address the discomfort and lack of style in traditional scrubs. This led to the creation of a brand focused on modern, high-quality, and comfortable healthcare clothing.

Heather Hasson, with her fashion background, and Trina Spear, bringing financial expertise from Blackstone Group, combined their skills to disrupt the status quo. Their goal was to provide healthcare professionals with apparel that was both functional and fashionable, a stark contrast to the outdated options available. The direct-to-consumer (DTC) model was a key part of their strategy, allowing them to control the entire process and build a strong brand.

The Growth Strategy of FIGS was built on a foundation of understanding the needs of healthcare workers. They started by selling their innovative scrubs directly from their car, gathering immediate feedback and refining their products. This hands-on approach was crucial for product development and building a loyal customer base. In the initial years, they secured funding to support production and expand their reach.

Icon

The Founding of FIGS

FIGS was founded in 2013 by Heather Hasson and Trina Spear, aiming to transform the medical apparel market.

  • Hasson, with a fashion background, and Spear, with finance experience, saw an opportunity to create better scrubs.
  • The initial capital came from their personal savings, and they raised a $2 million seed round in 2013.
  • They employed a direct-to-consumer (DTC) model, which was innovative in the healthcare clothing sector.
  • The company's early success was fueled by their commitment to quality and direct engagement with healthcare professionals.

FIGS SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

What Drove the Early Growth of FIGS?

The early growth of the FIGS company was marked by its innovative direct-to-consumer model, focusing on product innovation and community building. Founded in 2013, the company quickly secured funding rounds to fuel its expansion. This early period set the stage for the scrub brand's future success and its impact on the medical apparel industry.

Icon Funding Rounds and Early Investment

After initially bootstrapping, FIGS secured a $2 million seed round in 2013. Further funding came in 2014 and 2015, with an additional $3 million. In 2016, the Lululemon-backed venture capital fund, Campfire, led a Series A round, raising $5 million. This early investment was crucial for the company’s initial growth phase.

Icon Series B Funding and Expansion

A significant milestone was the $65 million Series B funding round in January 2018, led by Tulco. This brought FIGS's total funding to $75 million. This capital injection was essential for scaling operations and accelerating growth, enabling the company to expand its product offerings and reach a wider audience.

Icon Marketing and Brand Building

FIGS leveraged social media and influencer marketing to build brand awareness and connect with healthcare professionals. This strategy fostered a loyal customer base, crucial for the brand's growth. The company's approach helped differentiate it from other scrub brands and establish a strong market presence.

Icon Product Line Expansion and Retail Presence

The company expanded its product line beyond core scrubs to include lab coats, underscrubs, and accessories. In 2019, FIGS launched its first retail store, expanding beyond online sales. This omnichannel approach aimed to foster community engagement and bridge online and offline experiences, enhancing the brand's appeal.

Icon Revenue Growth and Financial Performance

By 2020, FIGS's revenues dramatically increased to $263 million, reaching $545 million in 2023. This growth demonstrates the company's successful business model and market penetration. The financial performance reflects the effectiveness of its strategies and the strong demand for its products.

Icon Social Responsibility and Community Impact

FIGS demonstrated a commitment to social responsibility through its 'Threads for Threads' initiative, donating scrubs to healthcare professionals in need in over 35 countries. By 2019, over 500,000 sets were donated. During the COVID-19 pandemic, FIGS donated 30,000 sets of scrubs to New York hospitals and contracted the production of over one million N95 masks for donation. For more information on the company's ownership and stakeholders, see Owners & Shareholders of FIGS.

Icon International Expansion

As of 2024, international sales represented 15% of total revenue, growing 31% year-over-year. This indicates significant expansion into global markets, showcasing the brand's increasing international presence and appeal. The company's ability to grow internationally highlights its strong brand and product demand.

FIGS PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

What are the key Milestones in FIGS history?

The FIGS company journey has been marked by significant achievements, transforming the medical apparel industry. From its inception, the company has consistently aimed to improve the experience of healthcare professionals through innovative design and strategic business decisions. The

FIGS history

is a testament to its growth and adaptation in a competitive market.
Year Milestone
2018 Ranked Number 21 on Inc. Magazine's Inc. 5000 list of fastest-growing companies.
May 2021 Completed Initial Public Offering (IPO), significantly increasing visibility and providing capital.
Ongoing Maintains a community-centric approach, fostering strong customer loyalty through campaigns featuring real healthcare professionals.

One of the most significant innovations is the proprietary FIONx fabric technology, which introduced four-way stretch, antimicrobial, anti-wrinkle, and moisture-wicking properties to scrubs. This technology improved comfort and durability, setting

FIGS scrubs

apart.
Icon

FIONx Fabric Technology

The development of FIONx fabric, offering four-way stretch, antimicrobial properties, and moisture-wicking capabilities, revolutionized

medical apparel

.
Icon

Specialized Collections

Launched specialized collections, such as the 'Extremes' line, designed for healthcare workers in demanding conditions.

Despite its successes, the company faces several challenges. While overall top-line growth was 2% year-over-year for 2024, the domestic market shows signs of stagnation. The company is also addressing increased operating expenses, partly due to a transition to a new fulfillment center and higher shipping costs.

Icon

Market Stagnation

The mature domestic market has shown signs of stagnation, with growth heavily reliant on international expansion.

Icon

Competitive Threats

Faces competition from brands like Jaanuu and Fabletics, which offer lower prices, impacting market share and pricing strategies.

Icon

Inventory Management

Experienced stock-outs in its footwear category in Q3 2024, highlighting inventory management challenges and supply chain issues.

Icon

Strategic Pivot

Implementing a strategic pivot with fewer discounts and more brand investment to reinforce its premium positioning and protect margins.

Icon

Sustainability Goals

Committed to sustainability, with targets such as reducing greenhouse gas emissions by 50% by 2030 and having 75% of scrub fabric from recycled materials by 2030.

FIGS Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What is the Timeline of Key Events for FIGS?

The FIGS company, a prominent name in the medical apparel industry, has a rich history marked by strategic growth and innovative approaches. Founded in Los Angeles, California, by Heather Hasson and Trina Spear, the company quickly gained traction, securing initial funding rounds and expanding its reach. It has revolutionized the healthcare clothing market. Their journey from a seed-funded startup to a publicly traded company reflects their successful evolution and impact on the healthcare sector.

Year Key Event
2013 FIGS was founded in Los Angeles, California, and secured a $2 million seed round.
2014-2015 The company raised an additional $3 million in funding to support its growth.
2016 Lululemon-backed Campfire led a Series A funding round, contributing $5 million.
2017 Thomas Tull invested $65 million, becoming a majority owner of the company.
January 2018 FIGS closed a $65 million Series B funding round, bringing total funding to $75 million.
2018 The company was ranked 21st on Inc. Magazine's Inc. 5000 list of fastest-growing companies.
2019 FIGS launched its first retail pop-up shop in Los Angeles and initiated the 'Threads for Threads' program, donating over 500,000 sets of scrubs.
Early 2020 The company donated 30,000 sets of scrubs and facilitated the production of over one million N95 masks during the COVID-19 pandemic.
May 2021 FIGS went public on the New York Stock Exchange (NYSE: FIGS).
2023 Reported $545 million in revenue, an 8% net revenue growth year-over-year.
2024 Reported $555.6 million in net revenues, a 1.8% increase year-over-year, with international sales representing 15% of revenue.
Q1 2025 Achieved 5% net revenue growth year-over-year, reaching $124.9 million.
Icon International Expansion

FIGS plans significant international expansion, with planned market entries into Japan (Q2 2025) and South Korea (second half of 2025). This strategic move recognizes that over 80% of healthcare professionals globally are outside the U.S., presenting a vast market opportunity for the scrub brand.

Icon Product Innovation and Diversification

Product innovation remains a central pillar, with plans to diversify offerings beyond scrubs into new categories like outerwear, footwear, and loungewear. The launch of innovative fabrications such as FORMx is also planned. These initiatives aim to expand the product range and enhance customer experience.

Icon TEAMS Program and Community Hubs

FIGS is developing its TEAMS program, targeting healthcare institutions, and hired a dedicated leader for this initiative in January 2025. The company also intends to deepen connections with customers through personalized products and expand its retail presence by opening at least three new 'Community Hubs' in the second half of 2025.

Icon Financial Strategy and Outlook

FIGS is strategically reducing promotional activities to reinforce its premium brand image and improve profit margins. The company maintains a strong cash position, with $251.2 million in cash and cash equivalents as of Q1 2025. Analysts project FIGS's earnings to grow by 40.2% per year and revenue by 2.5% per annum, with earnings per share (EPS) forecast to reach $0.08 for FY 2025 and $0.14 for FY 2026.

FIGS Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Related Blogs

Data Sources

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.